Yong-Tark Jeon
Overview
Explore the profile of Yong-Tark Jeon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cho H, Kim K, Jeon Y, Kim Y, No J
Med Sci Monit
. 2013 Mar;
19:230-5.
PMID: 23539074
Background: We aimed to identify clinical characteristics of ovarian mature cystic teratoma (MCT) in association with CA19-9 elevation, and to determine if CA19-9 is a useful marker in discrimination of...
2.
Kim H, Kim K, No J, Jeon Y, Jeon H, Kim Y
Anticancer Res
. 2012 Jan;
32(2):589-94.
PMID: 22287749
Background/aim: We aimed to investigate the prognostic value of biomarkers [Ki-67, adenosine triphosphate-binding cassette sub-family B member 1 (ABCB1), adenosine triphosphate-binding cassette sub-family C member 1 (ABCC1), adenosine triphosphate-binding cassette...
3.
No J, Kim M, Jeon Y, Kim Y, Song Y
Mol Carcinog
. 2011 Apr;
50(4):244-53.
PMID: 21465574
Human papillomavirus (HPV) is the necessary cause of cervical cancer. The HPV oncoproteins E6 and E7 have crucial roles in various steps of carcinogenesis, inducing degradation of p53 and destabilization...
4.
Lee C, Roh J, Choi J, Kang S, Park I, Chung H, et al.
Int J Gynecol Cancer
. 2011 Mar;
21(4):668-72.
PMID: 21412163
Introduction: Cyclooxygenase-2 (COX-2) is a well-known enzyme that promotes tumor growth and metastasis. Cyclooxygenase-2 is upregulated in a number of human epithelial tumors, but data about the significance of COX-2...
5.
No J, Jeon Y, Park I, Kim Y, Kim J, Park N, et al.
Gynecol Oncol
. 2011 Feb;
121(1):8-12.
PMID: 21276607
Objective: Activation of the mammalian target of rapamycin (mTOR) pathway enhances cell survival and growth by regulating the efficiency of protein translation. This study was conducted to evaluate the association...
6.
No J, Jeon Y, Kim Y, Song Y
Gynecol Obstet Invest
. 2010 Dec;
71(2):136-40.
PMID: 21160138
Objective: This study was conducted to determine the clinical significance of serum survivin in ovarian cancer. Methods: A total of 65 patients with ovarian tumors including 21 epithelial ovarian cancer,...
7.
No J, Jeon Y, Park I, Kang D, Kim J, Park N, et al.
Med Sci Monit
. 2009 Oct;
15(10):BR301-305.
PMID: 19789507
Background: Mammalian target of rapamycin (mTOR) plays a crucial role in carcinogenesis by regulating protein synthesis, and mTOR inhibitors have been identified as potential anticancer agents in various cancers. Since...
8.
Kim S, Kim S, Kim Y, Jeon Y, Lee S, Song Y
Ann N Y Acad Sci
. 2009 Sep;
1171:495-500.
PMID: 19723095
Genistein, a soy-derived isoflavone, inhibits growth of tumor cells from various malignancies. Here we investigated the effect of genistein on the growth of cervical cancer cells (HeLa and CaSki) and...
9.
Kim K, Jeon Y, Park I, Kim J, Park N, Kang S, et al.
Ann N Y Acad Sci
. 2009 Sep;
1171:111-5.
PMID: 19723044
To evaluate the role of cyclooxygenase (COX)-2 during cervical carcinogenesis, we investigated COX-2 expression in the dysplastic epithelium and stromal cells of cervical intraepithelial neoplasia (CIN). Immunohistochemical analysis with COX-2...
10.
Lee J, Im E, Kim S, Kim H, Kim Y, Jeon Y
J Gynecol Oncol
. 2009 May;
20(1):60-2.
PMID: 19471669
Malignant transformation of endometriosis is an infrequent complication. Clear cell carcinoma from endometriosis is very rare in the paraovarian cyst. To date no cases have been reported. We report a...